Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

500
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
500
Randomized Experiments01:13

Randomized Experiments

9.1K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
9.1K
Study Design in Statistics01:15

Study Design in Statistics

10.1K
A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
10.1K
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

333
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
333
Hazard Ratio01:12

Hazard Ratio

652
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
652
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

1.2K
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An interpretable deep learning framework for predictive modeling of postoperative infections in ICU patients.

PloS one·2026
Same author

GARD: Genomic Data-Based Drug Repurposing in Head and Neck Cancer with Large Language Model Validation.

Cancers·2026
Same author

Comprehensive analysis of mitophagy-related genes reveals prognostic signatures in breast cancer: based on immune landscapes and treatment target predict.

Frontiers in immunology·2026
Same author

PETScan: score-based genome-wide association analysis of RNA-Seq and ATAC-Seq data.

Bioinformatics (Oxford, England)·2026
Same author

Combined developmental toxicity of organophosphorus flame retardant TCEP and lead on zebrafish.

Ecotoxicology and environmental safety·2026
Same author

Epigenetic Age Acceleration and Hearing Function in US Older Adults.

Ear and hearing·2026

Related Experiment Video

Updated: Feb 23, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K

A model-based conditional power assessment for decision making in randomized controlled trial studies.

Baiming Zou1, Jianwen Cai2, Gary G Koch2

  • 1Department of Biostatistics, University of Florida, Gainesville, FL 32611, USA.

Statistics in Medicine
|September 5, 2017
PubMed
Summary
This summary is machine-generated.

This study introduces a model-based conditional power assessment for randomized controlled trials, offering a more flexible and powerful alternative to traditional methods for analyzing treatment effects and improving decision-making.

Keywords:
conditional powerconsistencymaximum likelihood estimatemultivariate normalnonlinear datarandomized controlled trial

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K
Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
07:05

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents

Published on: September 10, 2018

6.5K

Related Experiment Videos

Last Updated: Feb 23, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K
Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
07:05

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents

Published on: September 10, 2018

6.5K

Area of Science:

  • Biostatistics
  • Clinical Trials
  • Statistical Modeling

Background:

  • Conditional power is crucial for interim decision-making in randomized controlled trials (RCTs).
  • Traditional methods rely on simple summary statistics, limiting flexibility and power.
  • A need exists for advanced statistical strategies to enhance power and covariate handling in RCTs.

Purpose of the Study:

  • To extend traditional conditional power calculations using a general model-based strategy.
  • To develop an analytic, model-based conditional power assessment for both Gaussian and non-Gaussian data.
  • To improve the detection of treatment effects and control Type I error in RCTs.

Main Methods:

  • Developed a model-based conditional power assessment using regression models.
  • Established asymptotic relationships between interim and final parameter estimates.
  • Applied the method to Gaussian and non-Gaussian data, incorporating baseline covariates.

Main Results:

  • The model-based strategy demonstrated increased power for detecting treatment effects compared to conventional methods.
  • The approach proved robust in controlling overall Type I error, even with missing data.
  • The method showed flexibility in handling baseline covariates within the analysis.

Conclusions:

  • Model-based conditional power offers a more powerful and flexible approach for RCT decision-making.
  • This strategy enhances the analysis of treatment effects and statistical power.
  • The proposed method provides a robust framework for interim analyses in clinical studies.